InsidersTradesSigma
Follow the RELAY THERAPEUTICS INC share price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €4.3bn. The latest transaction was reported on 26 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: PETER RAHMER. Every trade is accessible without an account.
Analysts rate RELAY THERAPEUTICS INC Strong Buy (bullish), based on 13 analysts. Average price target: US$27.08.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
RELAY THERAPEUTICS INC es una empresa biofarmacéutica centrada en el desarrollo de terapias dirigidas para el tratamiento del cáncer y otras enfermedades. Utiliza tecnologías avanzadas para mejorar el descubrimiento de fármacos.